PAVmed (PAVM) Capital Expenditures (2016 - 2025)
PAVmed's (PAVM) quarterly Capital Expenditures came in at $14000.0 in Q4 2025, up 250.0% year-on-year from $4000.0 in Q4 2024, and up 366.67% quarter-over-quarter from $3000.0 in Q3 2025.
PAVmed (PAVM) Capital Expenditures (2016 - 2025) Analysis & Trends
PAVmed's Capital Expenditures history runs 10 years deep, the most recent figure standing at $14000.0 for Q4 2025.
- On a quarterly basis, Capital Expenditures rose 250.0% year-over-year to $14000.0 in Q4 2025; TTM through Dec 2025 was $31000.0, a 86.64% decrease from a year earlier, with the FY2025 full-year figure at $31000.0, down 43.64% from the prior year.
- Capital Expenditures improved to $14000.0 in Q4 2025 per PAVM's latest filing, from $3000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.3 million in Q4 2021 and bottomed at $3000.0 in Q2 2024.
- The 5-year median for Capital Expenditures is $35000.0 (2021), against an average of $175315.8.
- Across the five-year window, Capital Expenditures jumped 15862.5% in 2021 and tumbled 97.81% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $1.3 million in 2021, then slumped by 76.66% to $298000.0 in 2022, then sank by 38.59% to $183000.0 in 2023, then tumbled by 97.81% to $4000.0 in 2024, then surged by 250.0% to $14000.0 in 2025.
- Per Business Quant, the three latest PAVM Capital Expenditures figures stand at $14000.0 (Q4 2025), $3000.0 (Q3 2025), and $8000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | 14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 183,000.00 |
| Dec 31, 2023 | 183,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |